• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受腔内MRI引导下前列腺活检的PI-RADS 4类病变患者中,索引病灶的大小和数量在临床显著前列腺癌诊断中的作用。

The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy.

作者信息

Kilic Mert, Madendere Serdar, Vural Metin, Koseoglu Ersin, Balbay Mevlana Derya, Esen Tarik

机构信息

Department of Urology, VKF American Hospital, Güzelbahce Street No: 20, Teşvikiye, 34365, Istanbul, Turkey.

Department of Radiology, VKF American Hospital, Istanbul, Turkey.

出版信息

World J Urol. 2023 Feb;41(2):449-454. doi: 10.1007/s00345-022-04274-y. Epub 2023 Jan 3.

DOI:10.1007/s00345-022-04274-y
PMID:36595078
Abstract

PURPOSE

To evaluate the contribution of the size and number of the sampled lesions to the diagnosis of clinically significant prostate cancer (CSPC) in patients who had PI-RADS 4 lesions.

METHODS

In this retrospective study, a total of 159 patients who had PI-RADS 4 lesions and underwent In-bore MRI-Guided prostate biopsy were included. Patients with a lesion classified as Grade Group 2 and above were considered to have CSPC. Univariate and multivariate regression analyses were used to evaluate the factors affecting the diagnosis of prostate cancer (PCa) and CSPC.

RESULTS

A great majority (86.8%) of the patients were biopsy-naïve. About three-fourths (71.7%) had PCa, and half (54.1%) had CSPC. When the patients were divided into three groups according to the index lesion size (< 5 mm, 5-10 mm, and > 10 mm), the prevalence of PCa was 64.3, 67.5, and 82.4% and the prevalence of CSPC was 42.9, 51.2, and 64.7%, respectively. In multivariate analysis, age, index lesion size, prostate volume (< 50 ml) and being biopsy-naïve were found significant for PCa, while age and prostate volume (< 50 ml) were significant for CSPC.

CONCLUSION

The number of lesions was found to be insignificant in predicting PCa and CSPC. While the size of PI-RADS 4 lesions was significant in predicting PCa, it had no significance in detecting CSPC.

摘要

目的

评估在具有前列腺影像报告和数据系统(PI-RADS)4类病变的患者中,所取病变的大小和数量对临床显著前列腺癌(CSPC)诊断的贡献。

方法

在这项回顾性研究中,纳入了总共159例具有PI-RADS 4类病变并接受了磁共振引导下前列腺穿刺活检的患者。病变分类为2级及以上的患者被视为患有CSPC。采用单因素和多因素回归分析来评估影响前列腺癌(PCa)和CSPC诊断的因素。

结果

绝大多数(86.8%)患者为初次接受活检。约四分之三(71.7%)的患者患有PCa,半数(54.1%)患有CSPC。当根据索引病变大小将患者分为三组(<5毫米、5至10毫米和>10毫米)时,PCa的患病率分别为64.3%、67.5%和82.4%,CSPC的患病率分别为42.9%、51.2%和64.7%。在多因素分析中,年龄、索引病变大小、前列腺体积(<50毫升)和初次接受活检对PCa有显著影响,而年龄和前列腺体积(<50毫升)对CSPC有显著影响。

结论

发现病变数量在预测PCa和CSPC方面无显著意义。虽然PI-RADS 4类病变的大小在预测PCa方面有显著意义,但在检测CSPC方面无显著意义。

相似文献

1
The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy.在接受腔内MRI引导下前列腺活检的PI-RADS 4类病变患者中,索引病灶的大小和数量在临床显著前列腺癌诊断中的作用。
World J Urol. 2023 Feb;41(2):449-454. doi: 10.1007/s00345-022-04274-y. Epub 2023 Jan 3.
2
Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study.利用前列腺影像报告和数据系统(PI-RADS)评分选择最佳前列腺活检方法:Trio 研究的二次分析。
Eur Urol Oncol. 2022 Apr;5(2):176-186. doi: 10.1016/j.euo.2021.03.004. Epub 2021 Apr 10.
3
MRI in-bore biopsy following MRI/US fusion-guided biopsy in patients with persistent suspicion of clinically significant prostate cancer.在 MRI/US 融合引导活检后行 MRI 腔内活检用于持续怀疑有临床显著前列腺癌的患者。
Eur J Radiol. 2024 Jun;175:111436. doi: 10.1016/j.ejrad.2024.111436. Epub 2024 Mar 21.
4
Accuracy of Sampling PI-RADS 4-5 Index Lesions Alone by MRI-guided In-bore Biopsy in Biopsy-naive Patients Undergoing Radical Prostatectomy.MRI 引导下腔内活检对 PI-RADS 4-5 指数病变的采样准确率在初次接受根治性前列腺切除术的活检患者中的评估。
Eur Urol Focus. 2020 Mar 15;6(2):249-254. doi: 10.1016/j.euf.2019.04.010. Epub 2019 May 2.
5
Should Targeted Biopsy be Performed in Patients Who Have Only Pi-rads 3 Lesions?仅存在 PI-RADS 3 类病灶的患者是否应行靶向活检?
Arch Esp Urol. 2022 Jun;75(5):410-415. doi: 10.37554/en-j.arch.esp.urol-20210717-3506-26.
6
Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesions.针对前列腺影像报告和数据系统(PI-RADS)3-5级MRI病变的目标磁共振成像(MRI)扫描架内活检与认知引导经会阴或经直肠引导前列腺活检的比较。
BJU Int. 2017 Nov;120 Suppl 3:43-50. doi: 10.1111/bju.13971. Epub 2017 Sep 7.
7
Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial.经会阴前列腺融合活检中,使用 4 针靶向活检与 9 针靶向饱和活检检测临床显著前列腺癌:一项前瞻性随机试验。
Eur Urol Oncol. 2023 Feb;6(1):49-55. doi: 10.1016/j.euo.2022.08.005. Epub 2022 Sep 26.
8
Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.经直肠超声引导下随机活检发现前列腺癌,尽管实时磁共振成像/超声融合引导下靶向活检结果为阴性:靶向活检失败的原因
BJU Int. 2016 Jul;118(1):35-43. doi: 10.1111/bju.13327. Epub 2015 Oct 20.
9
Usefulness of grayscale values of hypoechoic lesions matched with target lesions observed on magnetic resonance imaging for the prediction of clinically significant prostate cancer.磁共振成像观察到的低回声病变的灰度值与靶病变匹配对预测临床显著前列腺癌的作用。
BMC Urol. 2022 Oct 29;22(1):164. doi: 10.1186/s12894-022-01111-7.
10
Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer.回顾性比较直接在管内磁共振成像(MRI)引导下活检和融合引导下活检在 MRI 病变患者中,这些病变可能或高度可能是临床上有意义的前列腺癌。
World J Urol. 2017 Dec;35(12):1849-1855. doi: 10.1007/s00345-017-2085-6. Epub 2017 Sep 4.

引用本文的文献

1
Does Machine Learning Prediction of Magnetic Resonance Imaging Prostate Imaging Reporting and Data System Correlate with Target Prostate Biopsy Results?磁共振成像前列腺影像报告和数据系统的机器学习预测与目标前列腺活检结果相关吗?
Med Princ Pract. 2025 May 26:1-9. doi: 10.1159/000546509.
2
Prostate cancer detection with transrectal in-bore MRI biopsies: impact of prostate volume and lesion features.经直肠腔内磁共振成像活检检测前列腺癌:前列腺体积和病变特征的影响
Insights Imaging. 2025 Mar 23;16(1):69. doi: 10.1186/s13244-025-01942-6.
3
An overview of utilizing artificial intelligence in localized prostate cancer imaging.

本文引用的文献

1
MRI determined prostate volume and the incidence of prostate cancer on MRI-fusion biopsy: a systemic review of reported data for the last 20 years.MRI测定的前列腺体积与MRI融合活检中前列腺癌的发病率:对过去20年报告数据的系统评价
Int Urol Nephrol. 2022 Dec;54(12):3047-3054. doi: 10.1007/s11255-022-03351-w. Epub 2022 Aug 30.
2
The Impact of Visible Tumor (PI-RADS ≥ 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis.低危前列腺癌患者根治性前列腺切除术中可见肿瘤(PI-RADS≥3)对病理升级及不良病理结果的影响:基于活检核心的分析
Clin Genitourin Cancer. 2022 Feb;20(1):e61-e67. doi: 10.1016/j.clgc.2021.09.007. Epub 2021 Oct 9.
3
局部前列腺癌成像中人工智能应用概述。
Expert Rev Med Devices. 2025 Apr;22(4):293-310. doi: 10.1080/17434440.2025.2477601. Epub 2025 Mar 19.
4
Does Size Matter? A Retrospective Study Analysing the Size of PI-RADS 4 Lesions and Its Associated Prostate Cancer Positivity with Transperineal Prostate Biopsy.大小重要吗?一项回顾性研究,分析经会阴前列腺穿刺活检中PI-RADS 4类病变的大小及其与前列腺癌阳性的相关性。
Res Rep Urol. 2025 Feb 25;17:49-57. doi: 10.2147/RRU.S499930. eCollection 2025.
5
Development and validation of a novel nomogram to avoid unnecessary biopsy in patients with PI-RADS category ≥ 4 lesions and PSA ≤ 20 ng/ml.开发和验证一种新的列线图,以避免在 PI-RADS 类别≥4 病变且 PSA≤20ng/ml 的患者中进行不必要的活检。
World J Urol. 2024 Aug 23;42(1):495. doi: 10.1007/s00345-024-05202-y.
6
[Predictive effect of the dual-parametric MRI modified maximum diameter of the lesions with PI-RADS 4 and 5 on the clinically significant prostate cancer].[双参数MRI修正病变最大径联合PI-RADS 4和5对临床显著前列腺癌的预测作用]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Aug 18;56(4):567-574. doi: 10.19723/j.issn.1671-167X.2024.04.004.
7
The Impact of Prostate Volume on the Prostate Imaging and Reporting Data System (PI-RADS) in a Real-World Setting.在实际临床环境中前列腺体积对前列腺影像报告和数据系统(PI-RADS)的影响。
Diagnostics (Basel). 2023 Aug 15;13(16):2677. doi: 10.3390/diagnostics13162677.
Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort.
对于接受磁共振成像检查的先前活检阴性的男性与活检初筛的男性相比,前列腺癌风险:PLUM 队列的前瞻性评估。
Cancer. 2022 Jan 1;128(1):75-84. doi: 10.1002/cncr.33875. Epub 2021 Aug 24.
4
Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level.PI-RADSv2.1 评估类别对癌症检测率的影响:基于病灶水平和患者水平的系统评价和荟萃分析。
Prostate Cancer Prostatic Dis. 2022 Feb;25(2):256-263. doi: 10.1038/s41391-021-00417-1. Epub 2021 Jul 6.
5
In-bore MRI-guided prostate biopsy in a patient group with PI-RADS 4 and 5 targets: A single center experience.在 PI-RADS 4 和 5 靶区的患者中进行管内 MRI 引导下前列腺活检:单中心经验。
Eur J Radiol. 2021 Aug;141:109785. doi: 10.1016/j.ejrad.2021.109785. Epub 2021 May 21.
6
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
7
Analysis of Magnetic Resonance Imaging-directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis.磁共振成像引导下的活检策略分析:改变前列腺癌诊断模式。
Eur Urol Oncol. 2020 Feb;3(1):32-41. doi: 10.1016/j.euo.2019.10.001. Epub 2019 Nov 7.
8
Necessity of differentiating small (< 10 mm) and large (≥ 10 mm) PI-RADS 4.有必要对 PI-RADS 4 评分小(< 10mm)和大(≥ 10mm)的前列腺癌进行区分。
World J Urol. 2020 Jun;38(6):1473-1479. doi: 10.1007/s00345-019-02924-2. Epub 2019 Aug 29.
9
Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.磁共振成像引导腔内和磁共振成像经直肠超声融合靶向前列腺活检:临床显著前列腺癌检出率的调整比较。
Eur Urol Oncol. 2019 Jul;2(4):397-404. doi: 10.1016/j.euo.2018.08.022. Epub 2018 Sep 20.
10
Epidemiology of Prostate Cancer.前列腺癌流行病学
World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20.